Journal
NATURE
Volume 457, Issue 7228, Pages 426-433Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nature07758
Keywords
-
Categories
Funding
- National Institutes of Health
Ask authors/readers for more resources
The discovery that gene expression can be controlled by the Watson - Crick base- pairing of small RNAs with messenger RNAs containing complementary sequence - a process known as RNA interference - has markedly advanced our understanding of eukaryotic gene regulation and function. The ability of short RNA sequences to modulate gene expression has provided a powerful tool with which to study gene function and is set to revolutionize the treatment of disease. Remarkably, despite being just one decade from its discovery, the phenomenon is already being used therapeutically in human clinical trials, and biotechnology companies that focus on RNA- interference- based therapeutics are already publicly traded.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available